Astrazeneca annual operating expenses
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Astrazeneca Operating Expenses Growth & History (AZN)
Astrazeneca's operating expenses was $34.36B for fiscal 2025.
View full Astrazeneca company overviewAstrazeneca annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $34.36B | $500.0M | +1.48% |
| 2024 | 2024-12-31 | $33.86B | $4.51B | +15.38% |
| 2023 | 2023-12-31 | $29.35B | $1.15B | +4.07% |
| 2022 | 2022-12-31 | $28.20B | $4.28B | +17.89% |
| 2021 | 2021-12-31 | $23.92B | $7.77B | +48.08% |
| 2020 | 2020-12-31 | $16.16B | −$383.0M | −2.32% |
| 2019 | 2019-12-31 | $16.54B | $2.77B | +20.14% |
| 2018 | 2018-12-31 | $13.77B | −$703.0M | −4.86% |
| 2017 | 2017-12-31 | $14.47B | $496.0M | +3.55% |
| 2016 | 2016-12-31 | $13.97B | −$1.97B | −12.38% |
| 2015 | 2015-12-31 | $15.95B | — | — |
Astrazeneca quarterly operating expenses
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.70B | $1.22B | +14.41% |
| Q1 2026 | 2026-03-31 | $8.36B | — | — |
| Q4 2025 | 2025-12-31 | $9.41B | — | — |
| Q3 2025 | 2025-09-30 | $8.81B | — | — |
| Q2 2025 | 2025-06-30 | $8.48B | $467.0M | +5.83% |
| Q2 2024 | 2024-06-30 | $8.01B | $1.01B | +14.41% |
| Q2 2023 | 2023-06-30 | $7.00B | −$234.0M | −3.23% |
| Q2 2022 | 2022-06-30 | $7.23B | $2.33B | +47.57% |
| Q2 2021 | 2021-06-30 | $4.90B | $895.0M | +22.34% |
| Q2 2020 | 2020-06-30 | $4.01B | −$260.0M | −6.09% |
| Q2 2019 | 2019-06-30 | $4.27B | $887.0M | +26.24% |
| Q2 2018 | 2018-06-30 | $3.38B | $204.0M | +6.42% |
| Q2 2017 | 2017-06-30 | $3.18B | — | — |
Astrazeneca operating expenses trends
Over the last five fiscal years, Astrazeneca's operating expenses increased from $16.16B to $34.36B, a change of $18.21B. The latest reported quarter, Q2 2026, shows $9.70B.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Astrazeneca source filings ↗Community posts
AstraZeneca receives US accelerated approval for Etcamah in a defined breast-cancer setting
AstraZeneca announced US accelerated approval of Etcamah on 7 September 2026. Approved setting Camizestrant, combined with a CDK4/6 inhibitor, is approved for adults with HR-positive, HER2-negative locally advanced or metastatic breast canc ...